Cite
MLA Citation
Peter Hillmen et al.. “Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL.” Acta oncologica, vol. 55, 2016, pp. 1115–1120. http://access.bl.uk/ark:/81055/vdc_100036709979.0x000058